Personalised, Rational, Efficacy-Driven Cancer Drug Dosing via an Artificial Intelligence SystEm (PRECISE): A Protocol for the PRECISE CURATE.AI Pilot Clinical Trial

Introduction: Oncologists have traditionally administered the maximum tolerated doses of drugs in chemotherapy. However, these toxicity-guided doses may lead to suboptimal efficacy. CURATE.AI is an indication-agnostic, mechanism-independent and efficacy-driven personalised dosing platform that may o...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Benjamin Kye Jyn, Teo, Chong Boon, Tadeo, Xavier, Peng, Siyu, Soh, Hazel Pei Lin, Du, Sherry De Xuan, Luo, Vilianty Wen Ya, Bandla, Aishwarya, Sundar, Raghav, Ho, Dean, Kee, Theodore Wonpeum, Blasiak, Agata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Digital Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8521832/
https://www.ncbi.nlm.nih.gov/pubmed/34713106
http://dx.doi.org/10.3389/fdgth.2021.635524

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8521832/
https://www.ncbi.nlm.nih.gov/pubmed/34713106
http://dx.doi.org/10.3389/fdgth.2021.635524

Ejemplares similares